Rh-negative blood is the blood type most associated with “rejecting” a pregnancy. When a mother has Rh-negative blood and her baby has Rh-positive blood, her immune system can treat the baby’s blood cells as foreign invaders and produce antibodies that cross the placenta and destroy them. This is called Rh incompatibility, and it’s the most clinically significant blood type mismatch in pregnancy. The good news: a simple, highly effective preventive treatment has existed since the 1970s.
How Rh Incompatibility Works
Your blood type has two parts: the letter group (A, B, AB, or O) and the Rh factor (positive or negative). The Rh factor is a protein on the surface of red blood cells. If you have it, you’re Rh-positive. If you don’t, you’re Rh-negative. Problems arise specifically when the mother is Rh-negative and the father is Rh-positive, because the baby may inherit the father’s Rh-positive blood.
During pregnancy, small amounts of fetal blood can cross the placenta into the mother’s bloodstream. When an Rh-negative mother’s immune system encounters those Rh-positive cells, it recognizes them as foreign and builds antibodies against them. Those antibodies can then cross back through the placenta and attack the baby’s red blood cells, destroying them. This process is called hemolytic disease of the newborn.
Why the First Pregnancy Is Usually Safe
The first Rh-incompatible pregnancy rarely causes serious problems. The mother’s body hasn’t had time to build up a large supply of antibodies yet. The real danger comes with subsequent pregnancies. Once sensitized, her immune system “remembers” the Rh-positive blood cells and mounts a faster, stronger antibody response the next time around.
Sensitization doesn’t only happen during a full-term delivery. The mixing of blood that triggers an immune response can also occur during a miscarriage, ectopic pregnancy, induced abortion, amniocentesis, or even abdominal trauma during pregnancy. Bleeding during pregnancy or procedures to manually turn a breech baby can also cause it. This means an Rh-negative woman can become sensitized even if her first pregnancy didn’t result in a live birth.
What Happens to the Baby
When maternal antibodies destroy a baby’s red blood cells, the baby develops anemia, sometimes severe. The consequences range from mild to life-threatening depending on how many antibodies are involved. Milder cases cause newborn jaundice that appears earlier and more intensely than normal. The baby’s liver and spleen may enlarge as they work overtime to compensate for the lost blood cells.
In the most severe cases, a condition called hydrops fetalis develops, where fluid accumulates throughout the baby’s body, including around the heart, lungs, and abdominal organs. This can lead to heart failure, respiratory failure, and death before or shortly after birth. These severe outcomes are now rare in countries with routine prenatal screening, but they still occur when incompatibility goes undetected or untreated.
What About ABO Incompatibility?
You might wonder whether mismatches in the letter part of blood type (A, B, AB, O) also cause problems. ABO incompatibility can occur, most commonly when the mother has type O blood and the baby has type A or B. But it’s far less dangerous than Rh incompatibility. ABO mismatches don’t typically trigger the kind of aggressive immune attack that Rh differences do, and they rarely cause problems during the pregnancy itself.
If ABO incompatibility causes any issues at all, they usually show up after birth as mild jaundice in the newborn. This is typically treated with phototherapy (light therapy) and resolves without lasting effects. No preventive medication is needed during pregnancy for ABO mismatches.
Prevention With Rh Immune Globulin
The standard prevention is an injection commonly known by the brand name RhoGAM. It contains antibodies that neutralize any Rh-positive fetal blood cells in the mother’s system before her immune system has a chance to react and build its own antibodies. Think of it as intercepting the alarm before the immune system sounds it.
The typical schedule involves two injections. The first is given around 26 to 28 weeks of pregnancy as a preventive measure. The second is given within 72 hours after delivery, once the baby’s blood type is confirmed as Rh-positive. If delivery happens within three weeks of the first dose, the postpartum injection may not be needed, though testing is done to confirm. Additional doses may be given after any event that could cause blood mixing, such as amniocentesis, bleeding episodes, or pregnancy loss beyond 12 weeks.
This approach has been remarkably effective. Before the treatment existed, roughly 13 to 16 percent of at-risk pregnancies resulted in sensitization. Postpartum treatment alone dropped that to about 0.5 to 1.8 percent. Adding the routine dose during pregnancy brought the risk down further to approximately 0.14 to 0.2 percent.
Who Is at Risk
Your risk depends on whether you’re Rh-negative, which varies significantly by ethnicity and geography. About 15 percent of people of European descent are Rh-negative, making it relatively common in countries like the United States, the United Kingdom, Australia, and much of Western Europe. In the U.S., roughly 15 percent of the population carries a negative Rh factor across all letter types combined.
The trait is much less common in other parts of the world. In East Asian countries like China and Japan, fewer than 1 percent of the population is Rh-negative. In India, it’s around 4 to 5 percent. Sub-Saharan African populations fall somewhere in between, with Nigeria at about 3 percent. Globally, roughly 6 percent of people are Rh-negative.
Being Rh-negative only matters in pregnancy if the baby is Rh-positive, which requires the father to be Rh-positive. If both parents are Rh-negative, every baby will also be Rh-negative, and there’s no incompatibility to worry about. This is why prenatal blood typing of the mother is standard practice early in pregnancy, and the father’s blood type is considered when assessing risk.
What Rh-Negative Women Should Know
If you’re Rh-negative, your blood type will be identified during routine early-pregnancy blood work. From there, your care provider will determine whether you need Rh immune globulin injections. The key points are straightforward: get the recommended injections on schedule, and make sure your Rh status is considered after any pregnancy event, including miscarriage or termination, not just full-term delivery. Sensitization from an early pregnancy loss can affect every future pregnancy.
If sensitization has already occurred (meaning your body has already produced anti-Rh antibodies), the immune globulin injections no longer help because they can only prevent an immune response, not reverse one. In these cases, the pregnancy is monitored more closely with regular blood tests and ultrasounds to watch for signs of fetal anemia, and interventions can be made if needed.